Found: 15
Select item for more details and to access through your institution.
Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial.
- Published in:
- Intensive Care Medicine, 2013, v. 39, n. 9, p. 1535, doi. 10.1007/s00134-013-2967-z
- By:
- Publication type:
- Article
The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2021, v. 13, n. 5, p. 488, doi. 10.1002/pmrj.12459
- By:
- Publication type:
- Article
Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Poster 90: Safety and Efficacy of Repeated Abobotulinumtoxin A Injections for Dynamic Equinus Foot in Children Less Than 6 Years of Age: A Subgroup Analysis.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2017, v. 9, n. 91, p. S165, doi. 10.1016/j.pmrj.2017.08.042
- By:
- Publication type:
- Article
Poster 71: AbobotulinumtoxinA Time to Retreatment Across 3 Phase 3 Spasticity Studies.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2017, v. 9, n. 91, p. S160, doi. 10.1016/j.pmrj.2017.08.028
- By:
- Publication type:
- Article
Poster 90: Safety and Efficacy of Repeated Abobotulinumtoxin A Injections for Dynamic Equinus Foot in Children Less Than 6 Years of Age: A Subgroup Analysis.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2017, v. 9, p. S165, doi. 10.1016/j.pmrj.2017.08.042
- By:
- Publication type:
- Article
Poster 71: AbobotulinumtoxinA Time to Retreatment Across 3 Phase 3 Spasticity Studies.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2017, v. 9, p. S160, doi. 10.1016/j.pmrj.2017.08.028
- By:
- Publication type:
- Article
Poster 292 Improvement of Spasticity Following AbobotulinumtoxinA (Dysport®) Injections in Shoulder Muscles in Hemiparetic Patients with Upper Limb Spasticity–Sub‐Analysis of a Prospective, Long‐Term, Open‐Label Study with Single and Repeated Injection Cycles.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2016, v. 8, n. 9, p. S255, doi. 10.1016/j.pmrj.2016.07.465
- By:
- Publication type:
- Article
Poster 292 Improvement of Spasticity Following AbobotulinumtoxinA (Dysport®) Injections in Shoulder Muscles in Hemiparetic Patients with Upper Limb Spasticity–Sub-Analysis of a Prospective, Long-Term, Open-Label Study with Single and Repeated Injection Cycles
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2016, v. 8, p. S255, doi. 10.1016/j.pmrj.2016.07.465
- By:
- Publication type:
- Article
Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat‐treatment study.
- Published in:
- Developmental Medicine & Child Neurology, 2021, v. 63, n. 5, p. 592, doi. 10.1111/dmcn.14733
- By:
- Publication type:
- Article
Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy.
- Published in:
- Journal of Child Neurology, 2017, v. 32, n. 13, p. 1058, doi. 10.1177/0883073817729918
- By:
- Publication type:
- Article
AbobotulinumtoxinA (Dysport®) Improves Function According to Goal Attainment in Children With Dynamic Equinus Due to Cerebral Palsy.
- Published in:
- Journal of Child Neurology, 2017, v. 32, n. 5, p. 482, doi. 10.1177/0883073816686910
- By:
- Publication type:
- Article
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome.
- Published in:
- BMC Cardiovascular Disorders, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12872-015-0015-3
- By:
- Publication type:
- Article